Other investigators have linked PARP1 hyperactivity to degenerative diseases such as diabetes, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism and injury induced brain disorders [1], [22], [55]–[58]. The gene discussed is PARP1; the disease is diabetes mellitus.